Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank10
3Y CAGR-44.1%
5Y CAGR-32.1%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-44.1%/yr
vs -1.4%/yr prior
5Y CAGR
-32.1%/yr
Recent deceleration
Acceleration
-42.7pp
Decelerating
Percentile
P10
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.97% |
| Q3 2025 | 5.10% |
| Q2 2025 | 1.80% |
| Q1 2025 | -0.57% |
| Q4 2024 | 0.85% |
| Q3 2024 | 3.76% |
| Q2 2024 | 5.00% |
| Q1 2024 | 3.90% |
| Q4 2023 | 2.85% |
| Q3 2023 | 4.91% |
| Q2 2023 | 1.99% |
| Q1 2023 | 2.89% |
| Q4 2022 | 5.55% |
| Q3 2022 | 1.73% |
| Q2 2022 | 3.25% |
| Q1 2022 | 3.59% |
| Q4 2021 | 7.45% |
| Q3 2021 | 10.17% |
| Q2 2021 | 20.90% |
| Q1 2021 | 3.55% |
| Q4 2020 | 6.71% |
| Q3 2020 | 11.47% |
| Q2 2020 | -8.43% |
| Q1 2020 | 6.43% |
| Q4 2019 | 6.21% |
| Q3 2019 | 5.81% |
| Q2 2019 | 2.48% |
| Q1 2019 | 9.55% |
| Q4 2018 | 8.60% |
| Q3 2018 | 8.58% |
| Q2 2018 | 6.18% |
| Q1 2018 | 6.94% |
| Q4 2017 | 0.72% |
| Q3 2017 | 7.34% |
| Q2 2017 | 3.70% |
| Q1 2017 | 12.10% |
| Q4 2016 | 2.13% |
| Q3 2016 | 10.04% |
| Q2 2016 | 5.09% |
| Q1 2016 | 5.27% |